Sun Pharma: Other income fillip - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

StockSelect
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Sun Pharma: Other income fillip

Nov 11, 2003

Domestic pharma major, Sun Pharma announced its 2QFY04 results recently. The company has reported a 13% growth in topline for the quarter. Despite a drop in the operating margins, strong other income growth has helped Sun Pharma register a 24% increase in bottomline. For 1HFY04, Sun Pharma has recorded an 11% growth in net sales and a 19% rise in net profits.

Results at a glance...
(Rs m) 2QFY03 2QFY04 Change 1HFY03 1HFY04 Change
Net Sales 2,166 2,452 13.2% 4,067 4,525 11.3%
Other Income 24 356 1403.0% 43 447 936.0%
Expenditure 1,550 2,036 31.4% 2,889 3,554 23.0%
Operating Profit (EBDIT) 617 416 -32.6% 1,178 971 -17.5%
Operating Profit Margin (%) 28.5% 17.0%   29.0% 21.5%  
Depreciation 50 54 9.3% 99 107 7.9%
Profit before Tax 591 718 21.5% 1,122 1,311 16.9%
Tax 58 57 -0.9% 108 104 -4.2%
Profit after Tax/(Loss) 533 661 23.9% 1,014 1,207 19.1%
Net profit margin (%) 24.6% 26.9%   24.9% 26.7%  
No. of Shares 93.6 92.8   93.6 92.8  
Diluted Earnings per share* 23.0 28.5   21.8 26.0  
P/E Ratio   21.1     23.1  
(* annualised)            

To Read the Full Story, Subscribe or Sign In
To Read the Full Story, Subscribe or Sign In


Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


Oct 1, 2020 02:43 PM

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUN PHARMA - ACTAVIS COMPARISON

COMPARE SUN PHARMA WITH

MARKET STATS